Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis

K Ramanathan, K Shekar, RR Ling, RP Barbaro… - Critical care, 2021 - Springer
Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …

Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. The 2020 GOLD science committee report on COVID-19 and …

DMG Halpin, GJ Criner, A Papi, D Singh… - American journal of …, 2021 - atsjournals.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has raised
many questions about the management of patients with chronic obstructive pulmonary …

Extracorporeal membrane oxygenation for COVID-19: updated 2021 guidelines from the extracorporeal life support organization

J Badulak, MV Antonini, CM Stead… - Asaio …, 2021 - journals.lww.com
Disclaimer: This is an updated guideline from the Extracorporeal Life Support Organization
(ELSO) for the role of extracorporeal membrane oxygenation (ECMO) for patients with …

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study

M Schmidt, D Hajage, G Lebreton, A Monsel… - The Lancet …, 2020 - thelancet.com
Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …

Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort …

G Lebreton, M Schmidt, M Ponnaiah… - The Lancet …, 2021 - thelancet.com
Background In the Île-de-France region (henceforth termed Greater Paris), extracorporeal
membrane oxygenation (ECMO) for severe acute respiratory distress syndrome (ARDS) was …

Coronavirus disease 2019–associated thrombosis and coagulopathy: review of the pathophysiological characteristics and implications for antithrombotic management

L Ortega‐Paz, D Capodanno… - Journal of the …, 2021 - Am Heart Assoc
Abstract Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe
acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global …

Severe covid-19

DA Berlin, RM Gulick, FJ Martinez - New England Journal of …, 2020 - Mass Medical Soc
Key Clinical Points Evaluation and Management of Severe Covid-19 Patients with severe
coronavirus disease 2019 (Covid-19) may become critically ill with acute respiratory distress …

Extracorporeal membrane oxygenation for cardiogenic shock: a meta-analysis of mortality and complications

S Rajsic, B Treml, D Jadzic, R Breitkopf… - Annals of intensive …, 2022 - Springer
Background Venoarterial extracorporeal membrane oxygenation (va-ECMO) is an advanced
life support for critically ill patients with refractory cardiogenic shock. This temporary support …

In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective …

R Lorusso, ME De Piero, S Mariani… - The Lancet …, 2023 - thelancet.com
Background Extracorporeal membrane oxygenation (ECMO) has been widely used in
patients with COVID-19, but uncertainty remains about the determinants of in-hospital …

Bleeding and thrombotic events in patients with severe COVID-19 supported with extracorporeal membrane oxygenation: a nationwide cohort study

A Mansour, E Flecher, M Schmidt, B Rozec… - Intensive Care …, 2022 - Springer
Purpose To describe bleeding and thrombotic events and their risk factors in patients
receiving extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease …